Trial · NCT02720107
Results by group17
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 17 of 17
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in T Cells Status (Decrease or Increase) at Month 48 (FAS) | Fingolimod | CD4+ Naïve T cells | -23.7 | Standard Error 0.62 | percentage of parent population |
| Change in T Cells Status (Decrease or Increase) at Month 48 (FAS) | Fingolimod | CD4+Central memory T cells | -1.2 | Standard Error 0.59 | percentage of parent population |
| Change in T Cells Status (Decrease or Increase) at Month 48 (FAS) | Fingolimod | CD4+ Effector memory T cells | 22.2 | Standard Error 2.37 | percentage of parent population |
| Change in T Cells Status (Decrease or Increase) at Month 48 (FAS) | Fingolimod | CD8+ Naïve T cells | -37.2 | Standard Error 0.38 | percentage of parent population |
| Change in T Cells Status (Decrease or Increase) at Month 48 (FAS) | Fingolimod | CD8+ Central memory T cells | -1.6 | Standard Error 0.07 | percentage of parent population |
| Change in T Cells Status (Decrease or Increase) at Month 48 (FAS) | Fingolimod | CD8+ Effector memory T cells | -12.9 | Standard Error 1.59 | percentage of parent population |
| Change in T Cells Status (Decrease or Increase) at Month 48 (FAS) | Fingolimod | TH17 central memory cells | -0.6 | Standard Error 0.03 | percentage of parent population |
| Percentage of Participants With Disability Progression as Measured by Expanded Disability Status Scale (EDSS) (FAS) | Fingolimod | 21.54 | percentage of participants | ||
| Change From Baseline in Disability Progression Assessed With the Expanded Disability Status Scale (EDSS) at Month 6 and Month 48 (FAS) | Fingolimod | Baseline | 2.7 | Standard Deviation 1.17 | scores on a scale |
| Change From Baseline in Disability Progression Assessed With the Expanded Disability Status Scale (EDSS) at Month 6 and Month 48 (FAS) | Fingolimod | Month 6 | 2.6 | Standard Deviation 1.38 | scores on a scale |
| Change From Baseline in Disability Progression Assessed With the Expanded Disability Status Scale (EDSS) at Month 6 and Month 48 (FAS) | Fingolimod | Month 48 | 2.7 | Standard Deviation 1.52 | scores on a scale |
| Change From Baseline in Disability Progression Assessed With the Expanded Disability Status Scale (EDSS) at Month 6 and Month 48 (FAS) | Fingolimod | Change from baseline to month 6 | -0.1 | Standard Deviation 0.69 | scores on a scale |
| Change From Baseline in Disability Progression Assessed With the Expanded Disability Status Scale (EDSS) at Month 6 and Month 48 (FAS) | Fingolimod | Change from month 6 to month 48 | 0.2 | Standard Deviation 1.18 | scores on a scale |
| Change From Baseline in Disability Progression Assessed With the Expanded Disability Status Scale (EDSS) at Month 6 and Month 48 (FAS) | Fingolimod | Change from baseline to month 48 | 0.0 | Standard Deviation 1.19 | scores on a scale |
| Change in Immune Status of B Cells, Monocytes and Natural Killer Cells (NK) Cells (FAS) | Fingolimod | B cells | -7.2 | Standard Error 0.42 | percentage of parent population |
| Change in Immune Status of B Cells, Monocytes and Natural Killer Cells (NK) Cells (FAS) | Fingolimod | Monocytes | 42.3 | Standard Error 2.03 | percentage of parent population |
| Change in Immune Status of B Cells, Monocytes and Natural Killer Cells (NK) Cells (FAS) | Fingolimod | Natural Killer cells | 28.0 | Standard Error 2.09 | percentage of parent population |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02720107/results